SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Return on Assets (ROA) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROA(%) | 16.06 | 12.02 | 6.45 | 5.85 | 8.04 |
What is the latest Return on Assets (ROA) ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Return on Assets (ROA) |
|---|---|
| Mar2026 | 16.06 |
| Mar2025 | 12.02 |
| Mar2024 | 6.45 |
| Mar2023 | 5.85 |
| Mar2022 | 8.04 |
How is Return on Assets (ROA) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Return on Assets (ROA) | % Change | |
|---|---|---|---|
| Mar2026 | 16.06 | 33.61 | |
| Mar2025 | 12.02 | 86.36 | |
| Mar2024 | 6.45 | 10.26 | |
| Mar2023 | 5.85 | -27.24 | |
| Mar2022 | 8.04 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Assets (ROA) ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,474.1 Cr | 8.8% | 28% | 14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 8.8% |
28% |
14.2% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses